Show
Sort by
-
- Journal Article
- A1
- open access
Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC
-
- Journal Article
- A1
- open access
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
-
Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials
-
European cancer organisation Essential Requirements for Quality Cancer Care (ERQCC) : lung cancer
-
Does nivolumab for progressed metastatic lung cancer fulfill its promises? : an efficacy and safety analysis in 20 general hospitals
-
- Journal Article
- A1
- open access
Wolf in sheep's clothing : primary lung cancer mimicking benign entities
-
Money rules the world
-
Endosonography for lung cancer staging: predictors for false-negative outcomes
-
Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England
-
Integrating early palliative care (EPC) in the management of lung cancer: the role of the thoracic oncologist